Joanna Gajuk
BofA Securities, Research Division

[Audio Gap] Bank of America Healthcare Conference. And my name is Joanna Gajuk. I cover health care providers at Bank of America. And now the session we have planned is with Chemed. It's a very interesting company because it's partially health care, but partially non-health care. So we try to hit on these other topics as well.

And today with us, we have the entire team. So we have Kevin McNamara, who's the CEO. We have Mike Witzeman, who's the CFO. And sorry, I'm looking at Joel, who's the CEO of VITAS.

Joanna Gajuk
BofA Securities, Research Division

So we're going to talk about VITAS first, to put you on the spot. But then I want to touch base on the other business as well because there are a lot of questions still floating around that business. But I guess when it comes to the hospice operations, Florida cap was an issue. It sounds like you guys doing much better on that front. And you did raise your census growth outlook for the year, right? So kind of the question is, what gives you confidence you can grow census and manage the Medicare Cap in Florida given the prior year experience?

Joel Wherley
President & CEO of VITAS Healthcare

Yes. As we talked about in the fourth quarter of last year, first quarter of the Medicare Cap year, we really wanted to see how that first quarter played out. We came